Aoki T, Kudo M, Nishida N, Ueshima K, Tsuchiya K, Tada T
J Gastroenterol. 2025; .
PMID: 40055288
DOI: 10.1007/s00535-025-02233-z.
Zhang J, Wang Z, Wu Q, Zeng J, Liu J, Zeng J
Sci Rep. 2024; 14(1):28103.
PMID: 39543345
PMC: 11564854.
DOI: 10.1038/s41598-024-79760-x.
Chen J, Chen Y, Hsieh K, Lee H, Chen C, Chen J
Medicina (Kaunas). 2024; 60(9).
PMID: 39336451
PMC: 11433876.
DOI: 10.3390/medicina60091410.
Yu Y, Wang X, Hu W, Chen D, Hu Z, Li S
J Hepatocell Carcinoma. 2024; 11:801-812.
PMID: 38737385
PMC: 11088842.
DOI: 10.2147/JHC.S438850.
Tanaka T, Ide T, Itoh K, Kai K, Noshiro H
Oncol Lett. 2024; 27(2):78.
PMID: 38192671
PMC: 10773218.
DOI: 10.3892/ol.2023.14211.
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.
Kudo M
Liver Cancer. 2023; 12(4):289-296.
PMID: 37901198
PMC: 10601881.
DOI: 10.1159/000532023.
Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China.
Ke Q, Guo Z, He J, Lai Z, Xin F, Zeng Y
J Hepatocell Carcinoma. 2023; 10:1353-1365.
PMID: 37605757
PMC: 10440086.
DOI: 10.2147/JHC.S420828.
Anatomical ablation for small hepatocellular carcinomas using multiple applicators: a preliminary study.
Kim J, Kim H, Yoon J, Joo I, Yoon J, Kim Y
Cancer Imaging. 2023; 23(1):78.
PMID: 37605251
PMC: 10440891.
DOI: 10.1186/s40644-023-00597-0.
From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
Fan Z, Jin M, Zhang L, Wang N, Li M, Wang C
Gut. 2023; 72(11):2149-2163.
PMID: 37549980
PMC: 10579519.
DOI: 10.1136/gutjnl-2023-330461.
Radiologic features of hepatocellular carcinoma related to prognosis.
Hwang S, Rhee H
J Liver Cancer. 2023; 23(1):143-156.
PMID: 37384030
PMC: 10202237.
DOI: 10.17998/jlc.2023.02.16.
Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.
Bai S, Yang P, Wei Y, Wang J, Lu C, Xia Y
Front Oncol. 2023; 13:1166327.
PMID: 37152055
PMC: 10154689.
DOI: 10.3389/fonc.2023.1166327.
Advances in Immunotherapy for Hepatocellular Carcinoma.
Hagiwara S, Nishida N, Kudo M
Cancers (Basel). 2023; 15(7).
PMID: 37046727
PMC: 10093619.
DOI: 10.3390/cancers15072070.
Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
Bai S, Yang P, Liu J, Xue H, Xia Y, Liu F
Oncologist. 2023; 28(8):e633-e644.
PMID: 37029989
PMC: 10400125.
DOI: 10.1093/oncolo/oyad088.
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma.
Kudo M
Liver Cancer. 2022; 11(5):399-406.
PMID: 36158590
PMC: 9485978.
DOI: 10.1159/000526163.
Role of preoperative prediction of microvascular invasion in hepatocellular carcinoma based on the texture of FDG PET image: A comparison of quantitative metabolic parameters and MRI.
Shi H, Duan Y, Shi J, Zhang W, Liu W, Shen B
Front Physiol. 2022; 13:928969.
PMID: 36035488
PMC: 9412047.
DOI: 10.3389/fphys.2022.928969.
Clinical and imaging features preoperative evaluation of histological grade and microvascular infiltration of hepatocellular carcinoma.
Zhang L, Lin J, Jia M, Zhang C, Xu R, Guo L
BMC Gastroenterol. 2022; 22(1):369.
PMID: 35915440
PMC: 9341046.
DOI: 10.1186/s12876-022-02449-w.
Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma.
Cheng C, Lai Y, Hung H, Lee J, Wang Y, Wu T
Front Surg. 2022; 9:926728.
PMID: 35910466
PMC: 9330627.
DOI: 10.3389/fsurg.2022.926728.
Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma.
Park E, Dezhbord M, Lee A, Park B, Kim K
Cancers (Basel). 2022; 14(15).
PMID: 35892823
PMC: 9329784.
DOI: 10.3390/cancers14153566.
Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
Jiang H, Wei J, Fu F, Wei H, Qin Y, Duan T
Liver Int. 2022; 42(5):1158-1172.
PMID: 35243749
PMC: 9314889.
DOI: 10.1111/liv.15231.
Surgical and oncological outcomes after laparoscopic open major hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Lu Q, Zhang N, Wang F, Chen X, Chen Z
Transl Cancer Res. 2022; 9(5):3324-3338.
PMID: 35117699
PMC: 8798952.
DOI: 10.21037/tcr.2020.04.01.